Despite ever stronger clinical cases and breakthrough evidence in pharmaceuticals, many of the industry’s hardest challenges persist, including slow adoption, entrenched habits, and uneven real-world impact.
In a sector built on data, decisions are still made by people. Prescribing, adherence, access, and policy are shaped as much by habit, context, trust, and identity as by evidence itself. When change stalls, the constraint is rarely informational; it is behavioural.
This is where the psychology of influence matters. We work with pharmaceutical organisations to identify the behaviour change targets that sit underneath strategic goals, and to design engagement that works with human behaviour rather than against it. Not by adding more data or louder messages, but by harnessing psychological realities to make the desired action easier, more natural, and more likely to endure.
